Umbilical Cord Blood (UCB) Transplantation in Pediatric Patients With High Risk Leukemia and Myelodysplasia
Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
Unrelated Cord Blood (UCB) transplant in children is a viable stem cell transplant modality
for patients with leukemia and myelodysplasia. UCB is now considered "Standard Of Care" in
cases where a suitable living bone marrow donor is not available. The survival of UCB is
similar to Matched Unrelated Marrow Transplant. This study is considered "Research" since UCB
is not a licensed product and requires investigational new drug (IND). THERE ARE NO SPECIFIC
RESEARCH QUESTIONS IN THIS PROTOCOL. This protocol merely provides UCB as a stem cell
treatment modality to pediatric patients who may require it after a conditioning regimen that
excludes Total Body Irradiation.